PhaseBio Pharmaceuticals Free Cash Flow Growth

Free Cash Flow Growth of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Free Cash Flow Growth for the quarter ending March 31, 2022 was -121.94% (a 35.62% increase compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow Growth increased by 520.56%
  • Annual Free Cash Flow Growth for 2021 was 18.37% (a -135.79% decrease from previous year)
  • Annual Free Cash Flow Growth for 2020 was -51.33% (a -62.3% decrease from previous year)
  • Annual Free Cash Flow Growth for 2019 was -136.16% (a 32.68% increase from previous year)
  • Twelve month Free Cash Flow Growth ending March 31, 2022 was -32.78% (a -278.44% decrease compared to previous quarter)
  • Twelve month trailing Free Cash Flow Growth decreased by -399.09% year-over-year
Trailing Free Cash Flow Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-32.78% 18.37% 36.24% 10.96%
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow Growth of PhaseBio Pharmaceuticals

Most recent Free Cash Flow Growthof PHAS including historical data for past 10 years.

Interactive Chart of Free Cash Flow Growth of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -121.94%
2021 -89.91% 57.7% -19.65% 57.8% 18.37%
2020 9.7% -85.35% 9.54% -177.77% -51.33%
2019 -82.28% -141.27% -160.22% -233.9% -136.16%
2018 -184.32% 40.74% 61.57% 70.05% -102.62%
2017 64.83% -68.73% 12.52%
2016 -14.31%

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology